A detailed history of Delta Global Management LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Delta Global Management LP holds 56,504 shares of EXAS stock, worth $3.22 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
56,504
Holding current value
$3.22 Million
% of portfolio
0.18%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$43.04 - $58.51 $2.43 Million - $3.31 Million
56,504 New
56,504 $2.45 Billion

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.1B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Delta Global Management LP Portfolio

Follow Delta Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Delta Global Management LP with notifications on news.